Skyrizi 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FZ0C9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,465
Award facts
- Contract value 100% obligated
- $16,465.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,465.33 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of SKYRIZI 150 mg/ml syringes with an ultimate completion date of December 10, 2025. This competitive, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive pharmaceutical support vehicle designated as SPE2DX and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania, maintains a significant portfolio of federal contracts with the Defense Logistics Agency and its Medical Supply Chain. The company has demonstrated consistent capability to fulfill federal medical procurement requirements through open competition, supplying an extensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare systems worldwide. This delivery order for SKYRIZI, a specialized pharmaceutical product, exemplifies the vendor's role in supplying critical medical commodities to the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26FZ0C9?
SPE2DR26FZ0C9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FZ0C9 worth?
The government has obligated $16,465 on SPE2DR26FZ0C9.
Is contract SPE2DR26FZ0C9 an order under another contract?
Yes. SPE2DR26FZ0C9 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FZ0C9 competed?
The extent of competition for SPE2DR26FZ0C9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award